Speakers' List

Geoffrey Coombs
Murdoch University, Australia
S1-1. Unique Evolution of CA-MRSA Clones
Doo-Ryeon Chung
Samsung Medical Center, Korea
S1-2. CA-MRSA as a new nosocomial pathogen
Robert Daum
The University of Chicago, USA
S1-3. A vaccine for Staphylococcus aureus?
Ian Gould
NHS Grampian, UK
S1-4. Treatment options for CA-MRSA infections
Hyuk-Joon Kwon
Seoul National University, Korea
S2-1. Recent highly pathogenic avian influenza outbreaks by H5N6 and H5N8 viruses and molecular risk assessment of mammalian pathogenicity
Nam-Hyuk Cho
Seoul National University College of Medicine, Korea
S2-2. Virological and immunological responses in MERS patients
Masayuki Saijo
National Institute of Infectious Diseases, Japan
S2-3. Clinical, epidemiological, and virological aspects of SFTS in Japan: what we have learned and what we should do?
Michael Osterholm
University of Minnesota, USA
S2-4. Infectious Diseases in the 21st Century: A Battle Plan for Survival
Po-Ren Hsueh
National Taiwan University Hospital, Chinese Taipei
S3-1. Colistin resistance in gram-negatives
Eun-Jeong Yoon
Research Institute of Bacterial Resistance, Korea
S3-2. Emergence of mcr-1 colistin resistance: a new story begins
Yohei Doi
University of Pittsburgh, USA
S3-3. What to use in the clinical practice?
Anucha Apisarnthanarak
Thammasat University Hospital, Thailand
S3-4. Colistin resistance: is it preventable?
S7-3. Active surveillance based on MDR gram-negative pathogens?
David Livermore
University of East Anglia, UK
S4-1. Carbapenemases from KPC to NDM to OXA-48: diverse enzymes in diverse clones
Kyungwon Lee
Yonsei University College of Medicine, Korea
S4-2. Diagnostic challenges in detecting carbapenem resistance
Ami Neuberger
Rambam Medical Center, Israel
S4-3. Antimicrobial treatment; recommendation and options for carbapenem-resistant Enterobacteriaceae
Linfa Wang
Duke-NUS Medical School, Singapore
S5-1. One Health lessons from investigation emerging viruses of bat origin
Yong Ho Park
Seoul National University, Korea
S5-2. One health approaches to zoonotic diseases and AMR
John Clemens
International Center for Diarrhoeal Disease Research, Bangladesh (icddr,b), Bangladesh
S5-3 One health activities on Nipah in Bangladesh: a high risk country for zoonotic disease spillover to man
Cheng-Hsun Chiu
Chang Gung Children's Hospital, Chinese Taipei
S6-1. Mycoplasma pneumoniae Infection in Children
Eun Hwa Choi
Seoul National University College of Medicine, Korea
S6-2. Macrolide-resistant Mycoplasma pneumoniae pneumonia in children
Nancy Henry
Mayo Clinic, USA
S6-3. Management of severe mycoplasma infection :
role of antibiotics and steroid
Stephan Harbarth
Geneva University Hospitals, Switzerland
S7-1. Knowledge gaps in hand hygiene monitoring and efficacy
Eun Ju Choo
Soonchunhyang University Hospital, Korea
S7-2. Fight against healthcare-borne flavivirus named HCV
Young Hwa Choi
Ajou University Hospital, Korea
S7-4. Ten-year experience of KONIS
Jong Hee Shin
Chonnam National University School of Medicine, Korea
S8-1. Diagnosis of fungal infections: current status
Thomas Patterson
UT Health San Antonio
S8-2. The newest treatment strategies for candidemia
Sharon Chen
University of Sydney, Australia
S8-3. Epidemiology and approach to management to invasive aspergillosis and mucormycosis
Louis Chai
National University Health System, Singapore
S8-4. Endemic fungal infection in the Asia-Pacific region (in the context of altered immunity)
Rossana Ditangco
Research Institute for Tropical Medicine, Philippines
S9-1. Preexposure prophylaxis: from science to implementation
Shuzo Matsushita
Center for AIDS Research/ Kumamoto University, Japan
S9-2. Broadly neutralizing antibody for treatment and prevention of HIV infection
Hyongbum Kim
Yonsei University College of Medicine, Korea
S9-3. Genome editing using programmable nucleases including CRISPR-Cas
Shui Shan Lee
The Chinese University of Hong Kong, Hong Kong, China
S9-4. Achievability of HIV treatment as prevention
Wang Hui
Peking University People's Hospital, PR China
S10-1. Epidemiology of extensively-resistant Gram-negative in Mainland China
Justin O'Grady
University of East Anglia, UK
S10-2. Improving the diagnosis and management of serious infection using rapid point-of-care metagenomic sequencing
Robin Patel
Mayo Clinic, USA
S10-3. NGS for infectious disease diagnosis and surveillance
Sunghoon Kim
Seoul National University /
Medicinal Bioconvergence Research Center, Korea
S11-1. Protein Synthesis Enzymes as Primary Defense System against Infection
Jung-Hyun Choi
Incheon St Mary's Hosp. The Catholic University of Korea, Korea
S11-2. Resuscitation in sepsis: reexamining the paradigm
Jaroslaw Zmijewski
University of Alabama at Birmingham, USA
S11-3. New therapeutic targets for sepsis: better late than never
Victor Lim
International Medical University, Malaysia
S12-1. The role of Behavioural Sciences in Antibiotic Stewardship
David Lye
Tan Tock Seng Hospital, Singapore
S12-2. Impact of ASP program on reducing AMR in the hospitals
Jacob Lee
Hallym University Kangnam Sacred Heart Hospital, Korea
S12-3. Computer decision support and surveillance systems for ASP